Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic RegimenKyoko Nitta, Daisuke Koya|BioMed Research International|2016Cited by 42